Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals Inc Cl A (NQ: RXRX )

6.290 -0.350 (-5.27%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,675,406
Open 6.830
Bid (Size) 6.340 (10)
Ask (Size) 6.350 (9)
Prev. Close 6.640
Today's Range 6.250 - 7.030
52wk Range 4.970 - 15.74
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AI-Powered Drug Discovery Firm Exscientia To Merge With Nvidia-Partner Recursion Pharmaceuticals
Exscientia merges with Recursion Pharmaceuticals in an all-stock deal. The new entity, named Recursion, will focus on industrializing drug discovery with advanced AI technologies, boasting $850 million... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
RXRX Stock Earnings: Recursion Pharmaceuticals Meets EPS, Beats Revenue for Q2 2024
RXRX stock results show that Recursion Pharmaceuticals met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
-36.27%
-36.27%
1 Month
-13.00%
-13.00%
3 Month
-26.86%
-26.86%
6 Month
-37.66%
-37.66%
1 Year
-36.97%
-36.97%

More News

Read More
CORRECTION - Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results
From Recursion Pharmaceuticals
Via GlobeNewswire
RXRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Recursion Pharmaceuticals, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Recursion updates L(earnings) call on August 8th to 8:30 am ET / 6:30 am MT
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8th
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities
From Recursion Pharmaceuticals, Inc.
Via GlobeNewswire
Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results
From Recursion Pharmaceuticals
Via GlobeNewswire
Is Recursion Pharmaceuticals a Millionaire-Maker?
Via The Motley Fool
99.9% of Nvidia's $380 Million Investment Portfolio Has Been Put to Work in These 4 Artificial Intelligence (AI)-Inspired Stocks
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD
Via Talk Markets
Down About 47% This Year: Is Recursion Pharmaceuticals a Buy on the Dip?
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
25 Best Artificial Intelligence Stocks to Buy Right Now
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
These 7 AI Stocks Were Major Movers On Monday/Tuesday - Here's Why
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Millionaire-Maker Artificial Intelligence (AI) Stocks
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD
Via Talk Markets
Is Recursion Pharmaceuticals Stock a Buy?
Via The Motley Fool
1 Reason to Buy Recursion Pharmaceuticals Stock and 2 Reasons to Sell
Via The Motley Fool
3 Healthcare Stocks Injecting AI for Big Gains
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
Via Benzinga
These Nvidia-Backed Artificial Intelligence (AI) Stocks Could Soar 73% to 89% Higher, According to Wall Street
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nvidia Is Buying Shares of These 5 AI Companies. Should You Do the Same?
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
Via InvestorPlace
Why SoundHound AI Stock Lost 22% Last Month
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Stocks This Amazon-Backed AI Says Will Turn $1K into $1M by 2030
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.